Kidney cancer accounts for 3 percent to 5 percent of all cancer cases. It is among the top 10 most common cancers. Kidney cancer may not cause any signs or symptoms in its early stages. It is often ...

Genentech, a member of the Roche Group (SIX: RO, ROP; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has approved Tecentriq ® (atezolizumab) and Tecentriq Hybreza ® ...

Regeneron presented new clinical data at ESMO 2026 on Libtayo use in high-risk CSCC and cancer-associated thrombosis.

Late-breaking Phase 3 C-POST data provide longer-term survival outcomes for adjuvant Libtayo ® (cemiplimab) in high-risk cutaneous squamous cell ...

Ashland resident Ann-Marie Ramsey survived breast cancer but, in her words, that was only the beginning of her journey.

The distance until you can say, 'I've already quit, so I'm fine'Working as an editor for a health magazine, I often have the opportunity to see readers' health checkup results. In those situations, ...

A doctor reassures a thyroid cancer patient that radioactive iodine treatment poses minimal risk to other organs, as it ...

Radioactive iodine passes through the heart and stomach quickly, targeting only thyroid and thyroid cancer cells with ...

Let’s hear it for the boys. What started as an innocent prank between guy friends ended as a potentially life-saving discovery for one man. Now, the recipient of the practical joke is issuing an ...

Hair loss and severe nausea are familiar images of cancer treatment, but they do not happen to everyone receiving radiation ...

Patients don’t feel the radiation as it’s delivered, and many treatments are provided in an outpatient setting.

Patients don’t feel the radiation as it’s delivered, and many treatments are provided in an outpatient setting.